VCYT - Veracyte Inc News Story
$46.91 -8.5 -15.3%
Last Trade - 04/03/21
| Market Cap | £2.26bn |
| Enterprise Value | £2.01bn |
| Revenue | £84.6m |
| Position in Universe | 1752nd / 6647 |
BRIEF-Caredx And Veracyte Announce Partnership For Transplant Rejection Testing On Ncounter System
Thu 14th May, 2020 1:59pm
May 14 (Reuters) - CareDx Inc CDNA.O :
* CAREDX AND VERACYTE ANNOUNCE EXCLUSIVE PARTNERSHIP FOR
TRANSPLANT REJECTION TESTING ON NCOUNTER SYSTEM
* CAREDX INC - CO WILL BECOME EXCLUSIVE WORLDWIDE
COMMERCIALIZATION PARTNER FOR SOLID ORGAN TRANSPLANT-REJECTION
TESTS ON VERACYTE'S DIAGNOSTIC PLATFORM
Source text for Eikon: ID:nBw7BSrSpa
Further company coverage: CDNA.O
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))
Recent news on Veracyte Inc
See all news
